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Neuroinvasion of prions: insights from mouse models
Abstract
The prion was defined by Stanley B. Prusiner as the infectious agent that causes transmissible
spongiform encephalopathies. A pathological protein accumulating in the brain of scrapie-infected
hamsters was isolated in 1982 and termed prion protein (PrPSc). Its cognate gene Prnp was identified
more than a decade ago by Charles Weissmann, and shown to encode the host protein PrP(C). Since the
latter discovery, transgenic mice have contributed many important insights into the field of prion
biology, including the understanding of the molecular basis of the species barrier for prions. By
disrupting the Prnp gene, it was shown that an organism that lacks PrP(C) is resistant to infection by
prions. Introduction of mutant PrP genes into PrP-deficient mice was used to investigate the
structure-activity relationship of the PrP gene with regard to scrapie susceptibility. Ectopic expression of
PrP in PrP knockout mice proved a useful tool for the identification of host cells competent for prion
replication. Finally, the availability of PrP knockout mice and transgenic mice overexpressing PrP
allows selective reconstitution experiments aimed at expressing PrP in neurografts or in specific
populations of haemato- and lymphopoietic cells. The latter studies have allowed us to clarify some of
the mechanisms of prion spread and disease pathogenesis.
Prevalence and clinical characteristics of prion diseases
Prion diseases or transmissible spongiform encephalopathies
(TSEs) are neurological disorders, characterized by dementia
and movement disorder. Histopathological changes of the
brain comprise a fine vacuolation, also termed spongiosis,
reactive changes of astrocytes (gliosis) and variable loss of
neurons. Typical examples of TSEs in humans are Creutzfeldt-
Jakob disease (Creutzfeldt, 1920) and Gerstmann-Straussler-
Scheinker syndrome (Gerstmann et al. 1936) which were first
described in the second and third decade of the 20th century.
While the prototype of prion diseases in animals, scrapie in
sheep and goats, has been known for more than two centuries,
a new form of animal prion disease designated bovine
spongiform encephalopathy (BSE) has since its first recognition
in 1986 developed into an epizootic (Wilesmith et al. 1992;
Anderson et al. 1996). The emergence of a new variant form
of Creutzfeldt-Jakob disease (nvCJD) in young people in the
UK has raised the possibility that BSE has spread to humans
by dietary exposure (Will et al. 1996, 1999). This fearful
scenario has recently been supported by experimental evidence
claiming that the agent causing BSE is indistinguishable from
that causing nvCJD (Hill et al. 1997a).
The molecular biology of prions
Although there is an increasing body of evidence, that the
infectious agent of transmissible spongiform encephalopathies,
the prion, partially or entirely consists of an abnormally folded
protein (McKinley et al. 1983; Prusiner et al. 1983; Oesch et
al. 1985), the nature of this agent is still under debate. The
possibility that the agent consists of viral particles can almost
certainly be ruled out, since no nucleic acids have been
detected. Since prions are distinguished from conventional
agents by their physicochemical properties, the protein-only
hypothesis has been formulated firstly by Griffith (1967) and
later, supported by additional experimental data by Prusiner
(1982). He coined the term prion, composed from the words
‘proteinaceous infectious agent’. The hypothesis states that the
agent is devoid of nucleic acid and consists solely of an
abnormal conformer of the cellular prion protein, PrP
C
. It has
been proposed that the partially protease-resistant and
detergent-insoluble PrP
Sc
is congruent with the infectious agent.
Two distinct models have been postulated to explain the
mechanism by which a misfolded form of PrP could catalyse
the refolding of native PrP molecules into the abnormal
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conformation and both models are the subjects of intensive
investigation: (i) the template-directed model, and (ii) the
nucleation-seeding model (Fig. 1). The first model assumes a
PrP
Sc
monomer promoting the conformational conversion of
PrP
C
, or of a partially destabilized intermediate, into the PrP
Sc
conformation (Prusiner, 1991). In this model PrP
Sc
would be
intrinsically more stable than PrP
C
, but kinetically inaccessible.
In the second model, formation of PrP
Sc
would be initiated by
a seed of aggregated PrP
Sc
triggering a nucleation-dependent
polymerization process (Jarrett & Lansbury, 1993). In contrast
to the template-directed model, the PrP
Sc
monomer is less
stable than PrP
C
but is stabilized upon joining to the PrP
Sc
aggregate.
However, both models demand an experimental proof.
Consistent with the nucleation model, cell-free conversion
studies indicate that PrP
Sc
aggregates are able to convert PrP
C
into a protease-resistant PrP isoform. On the other hand,
Riesner (Riesner et al. 1996) demonstrated that aggregates of
PrP
Sc
do not necessarily contain infectivity.
The role of PrP in prion disease
According to the protein-only hypothesis, PrP
C
is a substrate
for the PrP
Sc
-mediated conversion of PrP
C
into new PrP
Sc
molecules. An important corollary to this hypothesis is that an
organism lacking PrP
C
should be resistant to scrapie and
unable to propagate the infectious agent. To this end, Bueler
and colleagues generated mice with a targeted disruption of
the Prnp gene (Bueler et al. 1992). Although the ubiquitous
expression of PrP in the developing and adult central nervous
system (CNS) suggested a significant role in development and
function of the CNS, the resulting mice showed no overt
phenotype. In particular, they show no developmental defects,
no behavioural abnormalities and have a normal life expectancy.
Intracerebral inoculation of these mice with prions revealed
that they were resistant and did not propagate the agent,
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Figure 1
Models for the conformational conversion of PrP
C
into PrP
Sc
. Upper panel, the template-directed refolding
model postulates an interaction between exogenously produced PrP
Sc
and endogenous PrP
C
, which is induced
to transform itself into further PrP
Sc
. A high energy barrier may prevent spontaneous conversion of PrP
C
into
PrP
Sc
. Sporadic CJD may arise when spontaneous mutations in single cells lead to the conversion from PrP
C
to
PrP
Sc
and give rise to manifold subsequent conversions. Lower panel, the seeding or nucleation model
proposes that PrP
C
and Prp
Sc
are in a reversible thermodynamic equilibrium. Only if several monomeric PrP
Sc
molecules are mounted up to a highly ordered seed, can further monomeric PrP
Sc
be recruited and eventually
aggregated to amyloid. The likelihood of spontaneous formation of a seed is a function of the local PrP
Sc
concentration (which may be modulated by PrP
Sc
-binding proteins) and is inversely dependent upon the
number of monomers needed to form a proto-seed. Within such a crystal-like seed, PrP
Sc
becomes stabilized.
Fragmentataion of PrP
Sc
aggregates increases the number of nuclei which can recruit further PrP
Sc
and
therefore results in apparent replication of the agent.
thereby verifying the prediction of the protein-only hypothesis
(Bueler et al. 1993; Sailer et al. 1994). Heterozygous mice
with only one disrupted allele (Prnp
+ Ï0
) also showed partial
resistance to scrapie infection as manifested by prolonged
incubation times of about 290 days compared with about
160 days in Prnp
+Ï+
mice (Bueler et al. 1994). This suggests
that the amount of PrP
C
protein in the brain is a rate-limiting
step in the development of the disease may point to therapeutic
efforts aimed at reducing the production of the normal PrP
C
isoform.
Prion neurotoxicity: the neurografting approach
What is the pathogenetic event that impairs the central nervous
system? It is a common belief, that deposits of pathological
prion protein are to blame by inducing neuronal cell death
(Fairbairn et al. 1994; Giese et al. 1995), and among several
possible factors are elevated cytokine levels in the brain
(Campbell et al. 1994; Williams et al. 1994). To clarify,
whether or to what extent prions are directly neurotoxic, we
introduced a transplant which continuously delivered PrP
Sc
into the brains of Prnp
0Ï0
mice. This was accomplished by
grafting neural tissue overexpressing PrP into the brain of
PrP-deficient mice (Fig. 2). After intracerebral inoculation with
scrapie prions, these grafts not only developed severe signs of
neurodegeneration (Fig. 3) (Brandner et al. 1996, 1998) but
also accumulated high levels of PrP
Sc
and infectivity.
Substantial amounts of graft-derived PrP
Sc
migrated even into
distant areas of the host brain which then contained substantial
amounts of infectivity. But surprisingly, these brain areas did
not show pathological changes, not even in the immediate
vicinity of the grafts or the PrP deposits (Fig. 3) (Brandner et
al. 1996). We concluded that PrP
Sc
is inherently non-toxic and
PrP
Sc
plaques found in spongiform encephalopathies may be
an epiphenomenon rather than a cause of neuronal damage. It
is conceivable that PrP
Sc
is only toxic when it is formed and
accumulated within the cell but not when presented from
outside. Results from other researchers suggest that microglia
may play a certain role in mediating the toxic effect from
PrP
Sc
on PrP
C
-expressing neurons.
The neuroinvasion of prions
Although the intracerebral application is by far the most
effective route for prion infection, oral uptake is the
epidemiologically more relevant. This route is thought to be
responsible for the transmission not only of BSE but also of
new variant CJD (Hill et al. 1997b). Since prion diseases
primarily manifest as a disease of the CNS, invasion of prions
from the periphery must be of crucial importance and,
considering the precision of incubation times even after intra-
peritoneal inoculation, are tightly controlled. We therefore set
out to elucidate the mechanisms of prion spread from periphery
to the CNS. In a first set of experiments, we asked whether
prions can migrate from the periphery to a graft in the CNS of
a Prnp
0Ï0
mouse: intraperitoneal inoculation of such grafted
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Figure 2
Schematic drawing of the transplantation procedure to obtain PrP-expressing grafts within the brain of
Prnp
0Ï0
mice. Transgenic mice overexpressing PrP (termed tga20) were mated and embryos were removed at
day 13.5. The neuroectodermal brain anlage was removed and transplanted into the brain of an adult recipient
(Prnp
0Ï0
)mouse, where it differentiates into mature neuroectoderm. Inoculation with prions was carried out at
various time points after transplantation.
mice did not provoke any disease in the graft and did not
result in accumulation of prions in the spleen (Blattler et al.
1997). In contrast, wild-type mice develop scrapie and
accumulate high titres of infectivity in the lymphoreticular
system, shortly after intraperitoneal or intracerebral
inoculation. Then we asked, whether transfer of wild-type
bone marrow to into prnp
0Ï0
mice would restore prion
replication. First, Prnp
0Ï0
mice received intracerebral grafts
of Prnp overexpressing cells which eventually serves as an
indicator for infectivity brought into the CNS. Then, these
mice were irradiated and received bone marrow from wild-type
mice. After peripheral prion infection, there was infectivity
detectable in the spleen, but surprisingly no disease in the
CNS graft. We concluded, that the transport from the spleen
to the CNS requires another tissue compartment, which is not
restored by bone marrow reconstitution (Blattler et al. 1997).
A possible candidate is the peripheral nervous system, as
suggested by indirect findings.
The role of the lymphoreticular system in the
neuroinvasion of prions
Several studies indicate an important role of lymphoid organs
in prion replication, but there is little knowledge about which
cells support prion propagation in the lymphoreticular system.
Whole-body ionizing radiation studies in mice after intra-
peritoneal infection have suggested that the critical cells are
long lived (Fraser & Farquhar, 1987). Follicular dendritic cells
(FDCs) are possible candidates (Kitamoto et al. 1991), and
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Figure 3
Non-infected neural grafts in brains of Prnp
0Ï0
mice. Upper row (a—d), healthy control graft 230 days after
mock inoculation. The graft is located in the third ventricle of the recipient mouse (a, see asterisks,
haematoxylin—eosin), and shows no spongiform change, little gliosis (b, immunostain for glial fibrillary acidic
protein (GFAP)), and strong expression of synaptophysin (c) and of PrP
C
(d). Middle row (e—h), scrapie
infected graft 235 days after inoculation with increased cellularity (e), brisk gliosis (f) and a significant loss of
synaptophysin (g) and PrP (h) staining intensity is shown. Bottom row, high magnification of a similar
chronically infected graft shows characteristic pathological changes. i, appearance of large vacuoles and
ballooned neurons (arrow). In the GFAP immunostain (j), astrocytes appear wrapped around densely packed
neurons. Glandular deposits and intracytoplasmic accumulation of synaptophysin (k) and PrP immunoreactivity
(l) in the cytoplasm of neurons.
indeed PrP
Sc
accumulates in these cells of wild-type mice and
in mice with a selective T cell defect. Further evidence for the
importance of follicular dendritic cells came from experiments
with severe combined immunodeficiency (SCID) mice whose
FDCs are thought to be functionally impaired. In these mice,
intraperitoneal infection does not lead to replication of prions
in the spleen nor in the CNS. Reconstitution of SCID mice
with wild-type spleen cells restores susceptibility to scrapie
after peripheral infection (Fraser et al. 1996). These findings
suggest that components of the immune system are required
for efficient transfer of prions from the periphery to the CNS.
Thus, we analysed the role of other components of the
immune system which may contribute to neuroinvasion of
prions. We used mice with genetically engineered selective
inactivation of specific component of the immune system. We
used mice with defects of B and T cells (RAG_2
−Ï−
,
RAG_1
−Ï−
and SCID mice) and AGR
−Ï−
mice with an
additional defect of interferon áâ and interferon_ã. Defects of
B cells alone were assessed with ìMT
−Ï−
mice which not
produce any immunoglobulins but have complete and functional
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Figure 4
Latency of scrapie in various strains of immunodeficient mice. B cell-deficient mice remained healthy after i.p.
inoculation with the Rocky Mountain Laboratory (RML) scrapie prion strain as 100 ìl of a 10¢ or a 10¦Æ
dilution of a scrapie-infected brain homogenate (A; open circles). In contrast, all mice developed spongiform
encephalography after i.c. inoculation (B), regardless of their immune status. The horizontal lines represent
mean values.
T cell subsets. Isolated T cell defects were investigated with
CD4
−Ï−
, CD8
−Ï−
, âµ-microglobulin- or Perforin-deficient mice.
We found that defects affecting T cells had no apparent effect
on the incubation time after i.p. inoculation while all mutations
that disrupted the differentiation of B cells prevented the
development of clinical scrapie in i.p. inoculated mice
(Fig. 4A). Intracerebral inoculation of all these mice, however,
did not reveal any difference between the different groups
(Fig. 4B). These results seem to indicate a crucial role for
B cells in the propagation of scrapie after peripheral infection
(Klein et al. 1997). However, since mice devoid of B cells fail
to produce antibodies, and FDCs fail to develop in their
lymphoid organs, we asked which of these three factors might
be responsible for prion pathogenesis. Thus two further mouse
strains were investigated. To elucidate the role of immuno-
globulins we analysed mice producing antibody exclusively of
the IgM subclass (t11 ìMT), which had no detectable
specificity for PrP
C
. The role of FDCs was addressed using
mice that lacked functional FDCs (TNFR1
−Ï−
) but have
differentiated B cells. Both strains developed scrapie after
peripheral inoculation and again supported the notion of a
crucial role for differentiated B cells in neuroinvasive scrapie
(Klein et al. 1997).
PrP expression in B cells is not necessary for prion
neuroinvasion
Replication of prions and their transport from the periphery to
the CNS relies on the expression of PrP
C
on lymphocytes. Thus
we further asked, whether expression of PrP
C
on B cells was a
prerequisite for neuroinvasion of prions. Again, mice with
various immune defects (SCID, RAG 1
−Ï−
and ìMT
−Ï−
) were
used for adoptive transfer of fetal liver cells either from wild-
type or from Prnp
0Ï0
mice. This reconstitution induced the
formation of germinal centres in spleens of all mice, including
differentiation of FDCs. As control, we used B and T cell-
deficient mice reconstituted with FLCs from (B cell-deficient)
ìMT embryos, and found no follicular dendritic cells in
accordance with the notion that B cells or products thereof are
required for FDC maturation. Reconstituted mice were
challenged i.p. with scrapie prions. Surprisingly, all mice that
received FLCs of either genotype, Prnp
+Ï+
or Prnp
0Ï0
, from
immunocompetent donors developed scrapie after inoculation
with a high dose of prions, and most mice after a low dose.
Transfer of FLCs from ìMT donors, as well as omission of
the adoptive transfer procedure, did not restore susceptibility
to disease in any of the immunodeficient mice challenged with
the low dose. In a further step we asked whether spleen PrP
Sc
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Figure 5
Spleen history of Rag-1
−Ï−
mice reconstituted with Prnp
0Ï0
fetal liver cells. Upper row, paraffin sections
stained with hemalaun before FLC transfer (left). No B cell follicles and germinal centres were discernible in
Rag-1
−Ï−
mice. Restoration of organized B cell follicles and germinal centres after FLC reconstruction
(middle, magnification ² 200). Frozen sections immunostained with antibody FDC-M1 revealed formation of
prominent FDC clusters with germinal centres after FLC transfer (right, magnification, ² 250). Lower row,
confocal double-colour immunofluorescence analysis of splenic germinal centres in Rag-1
−Ï−
mice
reconstituted with Prnp
0Ï0
FLCs after i.p. inoculation with RML prions. Sections were stained with antibody
FDC-M1 to follicular dendritic cells (left) and with antiserum R340 to PrP (middle). Regions in which both
signals are detectable appear as a bright network within the follicle centre (right, magnification ² 250). Most
of the PrP signal in germinal centres appeared to co-localize with the FDC-network.
was associated with FDCs in FLC reconstituted mice. With
double-colour immunofluorescence confocal microscopy we
detected deposits of PrP-immunoreactive material in germinal
centres in spleens of reconstituted mice which largely
co_localized with the follicular dendritic network (Fig. 5)
(Klein et al. 1998).
These results support our notion that cells whose maturation
depends on B cells are responsible for accumulation of prions
in spleen. The most likely candidates are FDCs, since their
maturation correlates with the presence of B cells and the
formation of immune complexes.
On the other hand, it is equally possible that the follicular
dendritic network serves as a reservoir for the accumulation
and multiplication of prions. Other B cell-dependent processes
could enable the transfer of prions to autonomic nerve
terminals or the agent may be transported on or within B cells
directly within peripheral lymphoid tissue. Alternatively, anti-
bodies or other factors may bind prions, especially since PrP
can be detected by immunohistochemical stains in the germinal
centre area where immune complexing occurs, and this
formation may be of importance for mediating neuroinvasion
and facilitating the access to peripheral nervous system
terminals.
Current threats and future perspectives
What are the implications of the above findings in the
framework of the current epidemics of BSE and the occurrence
of nvCJD? For one thing, there is some evidence that nvCJD
is more lymphotropic than sporadic CJD, since nvCJD but not
sporadic CJD prions have been detected in tonsils and appendix.
Therefore understanding the peripheral pathogenesis is of
immediate importance in assessing risks of iatrogenic
transmission of human BSE via exposure to blood or tissues
from preclinical cases, and possibly from contaminated surgical
instruments, or even blood and blood products. It is
unfortunate that little is known about the distribution of
preclinical disease in the UK, leaving the actual persistence of
the agent in the population entirely obscure. What is
particularly unsettling about this lack of knowledge is the fact
that sensitive and reliable assays are now available for
detection of PrP
Sc
in lymphatic tissues of cadavers, and these
assays have been shown to constitute reliable indicators of
nvCJD. Given that the most problematic aspect in public health
decision-making is the uncertainty in prevalence of subclinical
disease, the use of such assays for unlinked anonymous
surveys of post-mortem material would seem to be logical,
imperative and extremely urgent for planning measures aimed
at limiting the spread of nvCJD among humans.
Our results indicate that follicular dendritic cells are most
probably the prion reservoir in lymphatic organs but also
splenic lymphocytes of experimentally inoculated mice can be
infected with prions. This finding raises an alert, because
blood lymphocytes might well be in equilibrium with their
splenic counterparts and may be relevant if blood donors are
subclinical carriers of the nvCJD agent (Aguzzi, 1997).
However, there are still controversies as to whether depletion
of leucocytes in blood products is necessary andÏor sufficient
to effectively prevent any possible risk.
Another consideration applies to secondary prophylaxis. As
mentioned above, there might be a considerable number of
preclinically infected people (Aguzzi & Collinge, 1997) who
may have acquired infectious BSE material via the human
food chain. It is a pressing issue to develop approaches that
will help control spread of the agent and that will hopefully
prevent the clinical outbreak of symptoms in these persons. In
light of the above findings, possible targets for the interference
with neuroinvasion are rate-limiting processes that control
prion replication within the infected individual. In light of the
knowledge discussed above, treatments that target the neuro-
immune interface of prion replication and neuroinvasion seem
a promising area for research aimed at post-exposure
prophylaxis.
Aguzzi, A. (1997). Neuro-immune connection in spread of prions in
the body? Lancet 349, 742—743.
Aguzzi, A. & Collinge, J. (1997). Post-exposure prophylaxis after
accidental prion inoculation. Lancet 350, 1519—1520.
Blattler, T., Brandner, S., Raeber, A. J., Klein, M. A.,
Voigtlander, T., Weissmann, C. & Aguzzi, A. (1997). PrP-
expressing tissue required for transfer of scrapie infectivity from
spleen to brain. Nature 389, 69—73.
Brandner, S., Isenmann, S., Kuhne, G. & Aguzzi, A. (1998).
Identification of the end stage of scrapie using infected neural grafts.
Brain Pathology 8, 19—27.
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A.,
Kobayashi, Y., Marino, S., Weissmann, C. & Aguzzi, A. (1996).
Normal host prion protein necessary for scrapie-induced
neurotoxicity. Nature 379, 339—343.
Bueler, H., Raeber, A., Sailer, A., Fischer, M., Aguzzi, A. &
Weissmann, C. (1994). High prion and PrPSc levels but delayed
onset of disease in scrapie-inoculated mice heterozygous for a
disrupted PrP gene. Molecular Medicine 1, 19—30.
Bueler, H. R., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P.,
Aguet, M. & Weissmann, C. (1993). Mice devoid of PrP are
resistant to scrapie. Cell 73, 1339—1347.
Bueler, H. R., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P.,
Dearmond, S. J., Prusiner, S. B., Aguet, M. & Weissmann, C.
(1992). Normal development and behaviour of mice lacking the
neuronal cell-surface PrP protein. Nature 356, 577—582.
Campbell, I. L., Eddleston, M., Kemper, P., Oldstone, M. B. &
Hobbs, M. V. (1994). Activation of cerebral cytokine gene expression
and its correlation with onset of reactive astrocyte and acute-phase
response gene expression in scrapie. Journal of Virology 68,
2383—2387.
Chazot, G., Broussolle, E., Lapras, C., Blattler, T., Aguzzi, A. &
Kopp, N. (1996). New variant of Creutzfeldt-Jakob disease in a 26-
year-old French man [letter]. Lancet 347, 1181.
Creutzfeldt, H. G. (1920). Uber eine eigenartige herdformige
Erkrankung des Zentralnervensystems. Zeitschrift der Gesellschaft
fur Neurologie und Psychiatrie 57, 1—19.
Fairbairn, D. W., Carnahan, K. G., Thwaits, R. N., Grigsby, R. V.,
Holyoak, G. R. & O’Neill, K. L. (1994). Detection of apoptosis
induced DNA cleavage in scrapie-infected sheep brain. FEMS
Microbiology Letters 115, 341—346.
Neuroinvasion of prions: insights from mouse modelsExp. Physiol. 85.6 711
Fraser, H., Brown, K. L., Stewart, K., McConnell, I., McBride, P.
& Williams, A. (1996). Replication of scrapie in spleens of scid
mice follows reconstitution with wild-type mouse bone marrow.
Journal of General Virology 77, 1935—1940.
Fraser, H. & Farquhar, C. F. (1987). Ionising radiation has no
influence on scrapie incubation period in mice. Veterinary
Microbiology 13, 211—223.
Gerstmann, J., Straussler, E. & Scheinker, I. (1936). Uber eine
eigenartige hereditar-familiare Erkrankung des Zentralnerven-
systems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen
Alterns. Zeitschrift fur Neurologie 154, 736—762.
Giese, A., Groschup, M. H., Hess, B. & Kretzschmar, H. A. (1995).
Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain
Pathology 5, 213—221.
Griffith, J. S. (1967). Self-replication and scrapie. Nature 215,
1043—1044.
Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C., Gowland, I.,
Collinge, J., Doey, L. J. & Lantos, P. (1997a). The same prion
strain causes vCJD and BSE [letter] [see comments]. Nature 389,
448—450.
Hill, A. F., Zeidler, M., Ironside, J. & Collinge, J. (1997b).
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
Lancet 349, 99.
Jarrett, J. T. & Lansbury, P. T. Jr (1993). Seeding ‘one-dimensional
crystallization’ of amyloid: a pathogenic mechanism in Alzheimer’s
disease and scrapie? Cell 73, 1055—1058.
Kitamoto, T., Muramoto, T., Mohri, S., Dohura, K. & Tateishi, J.
(1991). Abnormal isoform of prion protein accumulates in follicular
dendritic cells in mice with Creutzfeldt-Jakob disease. Journal of
Virology 65, 6292—6295.
Klein, M. A., Frigg, R., Flechsig, E., Raeber, A. J., Kalinke, U.,
Bluethmann, H., Bootz, F., Suter, M., Zinkernagel, R. M. &
Aguzzi, A. (1997). A crucial role for B cells in neuroinvasive scrapie.
Nature 390, 687—690.
Klein, M. A., Frigg, R., Raeber, A. J., Flechsig, E., Hegyi, I.,
Zinkernagel, R. M., Weissmann, C. & Aguzzi, A. (1998). PrP
expression in B lymphocytes is not required for prion neuroinvasion.
Nature Medicine 4, 1429—1433.
McKinley, M. P., Bolton, D. C. & Prusiner, S. B. (1983). A
protease-resistant protein is a structural component of the scrapie
prion. Cell 35, 57—62.
Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent,
S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B.,
Hood, L. E. & Weissmann, C. (1985). A cellular gene encodes
scrapie PrP 27—30 protein. Cell 40, 735—746.
Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause
scrapie. Science 216, 136—144.
Prusiner, S. B. (1991). Molecular biology of prion diseases. Science
252, 1515—1522.
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C.,
Bendheim, P. E., Groth, D. F. & Glenner, G. G. (1983). Scrapie
prions aggregate to form amyloid-like birefringent rods. Cell 35,
349—358.
Riesner, D., Kellings, K., Post, K., Wille, H., Serban, H., Groth,
D., Baldwin, M. A. & Prusiner, S. B. (1996). Disruption of prion
rods generates 10-nm spherical particles having high á_helical content
and lacking scrapie infectivity. Journal of Virology 70, 1714—1722.
Sailer, A., Bueler, H., Fischer, M., Aguzzi, A. & Weissmann, C.
(1994). No propagation of prions in mice devoid of PrP. Cell 77,
967—968.
Will, R., Cousens, S., Farrington, C., Smith, P., Knight, R. &
Ironside, J. (1999). Deaths from variant Creutzfeldt-Jakob disease.
Lancet 353, 9157—9158.
Will, R., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K.,
Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A. & Smith,
P. G. (1996). A new variant of Creutzfeldt-Jakob disease in the UK.
Lancet 347, 921—925.
Williams, A. E., van Dam, A. M., Man, A. H. W. K., Berkenbosch,
F., Eikelenboom, P. & Fraser, H. (1994). Cytokines, prostaglandins
and lipocortin-1 are present in the brains of scrapie-infected mice.
Brain Research 654, 200—206.
S. Brandner and others Exp. Physiol. 85.6712
